Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Innovation

    Chinese scientists use drop of blood to detect cancer

    CGTN | Updated: 2017-05-02 07:41
    Share
    Share - WeChat

    A group of Chinese scientists have invented a reagent test kit which can diagnose multiple kinds of cancer by analyzing a drop of human blood. [Photo/CGTN]

    Scientists around the world are striving for effective detection of cancer in the early stages, and a Chinese scientist may have found a quick way of knowing whether malignant tumors exist in a patient's body, with just one drop of blood.

    Luo Yongzhang and his team in Tsinghua University's School of Life Sciences in Beijing have successfully invented a reagent test kit of Hsp90α for clinical use, which can diagnose multiple kinds of cancer by analyzing a drop of human blood.

    Malignant tumors in early phases can be cured but once they have spread all over the patient's body there is no way to save the person's life.

    However, it's extremely difficult to be aware of cancer in its early stages, as patients don't show obvious symptoms and thus it can only be found in its later stages, which is already too late, so to detect cancer early remains a global challenge for scientists.

    Back in 1989, scientists have found a kind of heat shock proteins (HSP), named Hsp90α, which existed in human bodies and can be used as a cancer biomarker detection kit.

    Scientists around the globe have been working on it since then, and more than 10,000 journals have been published on accredited magazines, yet no one has actually turned their research results into medical products.

    However, Luo and his team seemed to have cracked the code, after working on the problem since 2009. The team has produced an artificial Hsp90α protein that gains structural stability by regrouping proteins. This means they are able to "create" the protein, in any quantity, and at any time they wish to.

    The kit has since been used in clinical trials involving 2,347 patients at eight hospitals in China. It was the first clinical trial in the world to test if the protein could be a useful tumor biomarker for lung cancer, and it succeeded.

    Now, the kit has been certified to enter the Chinese and European markets, 24 years after Hsp90α was discovered.

    Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.

    In 2015, about 90.5 million people had cancer in the world, with roughly 14.1 million new cases occurring each year. Approximately 8.8 million human deaths, or 15.7 percent of all deaths in the world, are caused by cancer.

    In China alone, 4.29 million people were detected as having cancer in 2015, and 2.8 million of them died in that year.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    人妻无码一区二区不卡无码av| 中文字幕无码av激情不卡久久 | 在线综合亚洲中文精品| 亚洲日韩欧洲无码av夜夜摸| 日本妇人成熟免费中文字幕| 无码av免费网站| 中文字幕一区二区免费| 中文字幕亚洲乱码熟女一区二区| 亚洲av永久无码精品漫画 | 一本大道香蕉中文日本不卡高清二区| 精品无码国产一区二区三区51安| 人妻AV中出无码内射| 亚洲精品无码鲁网中文电影| 秋霞鲁丝片Av无码少妇| 日韩av无码中文无码电影| 一本一道AV无码中文字幕| 国产综合无码一区二区三区| 亚洲第一极品精品无码久久| 久久久久综合中文字幕| 国色天香中文字幕在线视频| 6080YYY午夜理论片中无码 | 中文字幕亚洲一区| 台湾佬中文娱乐中文| 狠狠躁天天躁中文字幕无码| 人妻无码精品久久亚瑟影视| 成人免费无码H在线观看不卡| 亚洲AV综合色区无码另类小说 | 亚洲AV永久无码精品一百度影院| 熟妇女人妻丰满少妇中文字幕| 人妻AV中文字幕一区二区三区| 国产 日韩 中文字幕 制服| 免费无码AV一区二区| 国产高清无码二区 | 中文无码喷潮在线播放| 日韩精品无码永久免费网站 | 无码人妻一区二区三区精品视频| 东京热加勒比无码视频| 国产亚洲AV无码AV男人的天堂| 少妇无码一区二区三区| 人妻无码久久一区二区三区免费| 无码专区久久综合久中文字幕 |